Allotment

Amanta Healthcare Limited is launching a book-built IPO of ₹126.00 crore, consisting entirely of a fresh issue of 1 crore shares at a price of ₹126 per share. The IPO bidding opened on September 1, 2025, and closed on September 3, 2025, with allotment finalized on September 4, 2025. The shares were subsequently listed on BSE and NSE on September 9, 2025.
The IPO has a price band of ₹126 per share. Retail investors can apply for a minimum of 119 shares (₹14,994), while small non-institutional investors can subscribe for 1,666 shares (₹2,09,916) and big non-institutional investors for 7,973 shares (₹10,04,598).
Beeline Capital Advisors Pvt. Ltd. is the book-running lead manager, and MUFG Intime India Pvt. Ltd. is the registrar of the issue. This IPO provides investors an opportunity to participate in Amanta Healthcare’s growth across domestic and international pharmaceutical markets.
₹1260%
Open
HIgh - Low
Previous Close
Total Traded Value
52 Weeks High
52 Weeks Low
Updates On
IPO. Open
IPO. Close
IPO. Price
IPO Market price
| IPO Date | 9 Sep |
| IPO Listing Date | 9 Sep |
| IPO Face Value | RS.10 |
| IPO Price Range | ₹126.00 |
| IPO Issue Size | 1,00,00,000 shares |
| IPO Sale Type | Fresh Capital |
| Employee Discount | - |
| IPO Issue Type | Bookbuilding IPO |
| IPO Listing | BSE NSE Platform |
| Share Holding Pre Issue | 2,88,29,351 shares |
| IPO Open Date | 1 Sep |
| IPO Close Date | 3 Sep |
| IPO Allotment (Tentative) | 4 Sep |
| Refunds | 8 Sep |
| Credit to Demat Account | 8 Sep |
| IPO Listing Date | 9 Sep |
| Category | Offer |
|---|---|
| QIB Shares Offered | 50,00,000 Shares |
| NII (HNI) Shares Offered | 15,00,000 Shares |
| Retail Shares Offered | 35,00,000 Shares |
Investors can bid for a minimum of 119 shares, with additional shares to be purchased in multiples of 119.
| Application | Lots | Share | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 119 | ₹14,994 |
| Retail (Max) | 13 | 1,547 | ₹1,94,922 |
| S-HNI (Min) | 14 | 1,666 | ₹2,09,916 |
| S-HNI (Max) | 66 | 7,854 | ₹9,89,604 |
| B-HNI (Min) | 67 | 7,973 | ₹10,04,598 |
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company specializing in the development, manufacturing, and marketing of a wide range of sterile liquid products, particularly parenteral formulations. These products are packaged in plastic containers using advanced Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. The company also manufactures medical devices.
Amanta Healthcare produces fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. Its medical device segment offers irrigation solutions, first-aid products, and eye lubricants.
The company markets its products through three key business units:
National Sales
International Sales
Product Partnering, collaborating with various Indian and international pharmaceutical companies
With a portfolio of over 45 generic products, Amanta Healthcare markets its branded products in India through a network of 320 distributors and stockists. Internationally, the company sells to regions including Africa, Latin America, and the UK, with products registered in 19 countries and compliant with global regulatory standards. In fiscal 2025, the company exported branded products to 21 countries.
As of March 31, 2025, Amanta Healthcare employs 1,718 professionals across formulation, development, and quality laboratories.
Competitive Strengths
Established manufacturer with a diverse pharmaceutical product portfolio and broad market presence
Large-scale manufacturing capabilities
Extensive domestic and international marketing network
Experienced management team supported by a skilled and diverse workforce
| Assets | 381.76 | 352.12 | 374.06 |
| Total Income | 276.09 | 281.61 | 262.7 |
| Profit After Tax | 10.5 | 3.63 | -2.11 |
| EBITDA | 61.05 | 58.76 | 56.31 |
| NET Worth | 96.39 | 66.29 | 62.88 |
| Reserves and Surplus | 67.56 | 39.46 | 36.05 |
| Total Borrowing | 195 | 205.23 | 215.66 |
| ROE | 12.42% |
| ROCE | 13.72% |
| Debt/Equity | 2.02 |
| RoNW | 10.89% |
| PAT Margin | 3.86% |
| EBITDA Margin | 22.11% |
| Price to Book Value | 3.77 |
IPO Objects of the Issue
| S.No. | Objects of the ipo Resources Detail | IPO Amount |
|---|---|---|
| 1 | Funding capital expenditure requirements for the purchase of equipment/machineries | 70 |
| 2 | To meet out the expenses of Working Capital Requirement | - |
| 3 | To meet out the General Corporate Purposes; | 6.6 |
| 4 | Offer for Sale (OFS) | - |
Amanta Healthcare Ltd. Address
8th Floor, Shaligram Corporates
C.J. Marg
Ambli,
Ahmedabad, Gujarat, 380058
079 67777600
cs@amanta.co.in
IPO Registrar
MUFG Intime India Pvt.Ltd.
+91-22-4918 6270
amantahealthcare.ipo@linkintime.co.in